Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Deficit) and Capitalization (Detail Textuals)

v3.20.4
Stockholders' Equity (Deficit) and Capitalization (Detail Textuals) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 31, 2020
Nov. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Equity [Line Items]        
Common stock, shares authorized     500,000,000 500,000,000
Stock issuance costs     $ 0 $ 9,301
Proceeds from Issuance of Common Stock     $ 6,085,589 $ 1,919,372
2018 Emerald Financing Warrants        
Equity [Line Items]        
Warrants exercise       40,800,000
Intrinsic value of warrant exercises       $ 4,284,000
Warrant exercise price     $ 0.10  
Warrants to purchase an aggregate shares of common stock       40,800,000
Pre-funded Warrants        
Equity [Line Items]        
Warrants exercise     48,533,334  
Intrinsic value of warrant exercises     $ 2,104,667  
Warrants to purchase an aggregate shares of common stock     48,533,334  
Series B Warrants        
Equity [Line Items]        
Warrants exercise     312,500 187,500
Intrinsic value of warrant exercises     $ 26,563 $ 144,375
Warrant exercise price     $ 0.00  
Warrants to purchase an aggregate shares of common stock     312,500 187,500
Direct offering        
Equity [Line Items]        
Number of warrants exercised   8,000,000    
Common stock, par value (per share)   $ 0.001    
Net proceeds from the transaction   $ 1,919,372    
Warrants to purchase an aggregate shares of common stock   8,000,000    
Securities Purchase Agreement | Institutional investors and H.C. Wainwright & Co., LLC | Direct offering        
Equity [Line Items]        
Number of common stock units sold 56,333,334      
Number of pre-funded units sold 60,333,334      
Common units sold price per unit $ 0.06      
Pre-funded units sold price per unit $ 0.059      
Gross proceeds of units sold $ 6,939,667      
Warrants and rights outstanding term 5 years      
Stock issuance costs $ 854,078      
Proceeds from Issuance of Common Stock $ 6,085,589      
Securities Purchase Agreement | Institutional investors and H.C. Wainwright & Co., LLC | Direct offering | Placement agent        
Equity [Line Items]        
Warrants and rights outstanding term 5 years      
Warrants to purchase an aggregate shares of common stock 8,166,667      
Percentage of total shares of common stock and pre-funded warrants sold in offering 7.00%      
Securities Purchase Agreement | Institutional investors and H.C. Wainwright & Co., LLC | Direct offering | Pre-funded Warrants        
Equity [Line Items]        
Common stock and pre-funded stock units sold description each consisting of one pre-funded warrant to purchase one share of common stock and one warrant to purchase one share of common stock      
Warrant exercise price $ 0.001      
Securities Purchase Agreement | Institutional investors and H.C. Wainwright & Co., LLC | Direct offering | Common Stock Warrants        
Equity [Line Items]        
Common stock and pre-funded stock units sold description each consisting of one share of common stock and one warrant to purchase one share of common stock      
Warrant exercise price $ 0.06